...

Module

Nonalcoholic Fatty Liver Disease

Source: Hepatitis Annual Update 2005

Nonalcoholic Fatty Liver Disease


CME Program Director: Patrick J. Lynch, MD

Faculty:

Arun J. Sanyal, MBBS, MD
  • Arun J. Sanyal, MBBS, MD

CREDIT INFORMATION

Release Date: October 13, 2005

Expiration Date: October 12, 2006


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe optimal management of nonalcoholic fatty liver disease and emerging pharmacologic treatments for nonalcoholic steatohepatitis

  • Discuss the association between nonalcoholic fatty liver disease and insulin resistance

  • Review strategies for the diagnosis of nonalcoholic fatty liver disease


Content includes:

  • Relationship of Insulin Resistance with NAFLD
  • Metabolic and Biochemical Consequences of Insulin Resistance
  • Insulin Resistance and the Development of a Fatty Liver
  • From Fatty Liver to Steatohepatitis: Insulin Resistance and the Two-Hit Hypothesis
  • Role of Mitochondria
  • Cytochrome P-450
  • Other Factors Produced by Hepatocytes or Adjacent Cells
  • Role of Antioxidant Mechanisms
  • How Oxidative Stress Produces the Phenotype of Steatohepatitis
  • Determining NAFLD Diagnosis
  • Management of NAFLD
  • Pharmacologic Treatment of NASH: Insulin Resistance Drugs
  • Lipid-Lowering Agents
  • Drugs That Protect Hepatocytes
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.